CONMED CORPORATION Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CONMED CORPORATION payments for repurchase of common stock for the quarter ending 2015-12-31 was $0.00.
- CONMED CORPORATION payments for repurchase of common stock for the quarter ending 2015-09-30 was $0.00.
- CONMED CORPORATION payments for repurchase of common stock for the quarter ending 2015-06-30 was $0.00.
- CONMED CORPORATION payments for repurchase of common stock for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- CONMED CORPORATION payments for repurchase of common stock for fiscal 2016 was $0.00.
- CONMED CORPORATION payments for repurchase of common stock for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CONMED CORPORATION payments for repurchase of common stock for fiscal 2014 was $16.86M, a 66.65% decline from fiscal 2013.
- CONMED CORPORATION payments for repurchase of common stock for fiscal 2013 was $50.56M, a 1188.71% increase from fiscal 2012.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 10-K · filed 2017-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-27 | $0.00 derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $0.00 10-Q · filed 2015-04-24 | $0.00 derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $16.86M 10-K · filed 2017-02-27 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-23 | $22.69M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-27 | $22.69M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $16.86M 10-Q · filed 2015-04-24 | $41.69M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $50.56M 10-K · filed 2016-02-23 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $48.65M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $48.65M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $25.73M 10-Q · filed 2014-04-25 | $29.66M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $3.92M 10-K · filed 2015-02-23 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $0.00 derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $15.02M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $0.00 10-Q · filed 2013-04-29 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $15.02M 10-K · filed 2014-02-24 |
| 2011-09-30 | $15.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $22.98M 10-K · filed 2013-02-25 |
| 2010-09-30 | $32.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | |
| 2009-12-31 | $0.00 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |